Risperdal Continues to Boggle Down Johnson & Johnson
Trouble is no stranger to Johnson & Johnson. Johnson and Johnson (J&J), embroiled in massive litigation in DePuy ASR artificial hips, and in transvaginal mesh litigation from its Ethicon Gynecare products, faces more legal issues from its anti-psychotic drug, Risperdal. Currently, Johnson & Johnson is appealing a 1.2 billion dollar fine issued in an Arkansas [...]